Robert L. Redner

ORCID: 0000-0002-2042-296X

Also affiliated with University of Pittsburgh Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years”.

A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0091

N/A

0.216DataRank · unranked

3 citations

Ronan Swords, Ying Huang, Shelley Orwick, Daelynn R. Buelow, Nicole Abbott +23 more

Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy

Leukemia & lymphoma/Leukemia and lymphoma(2023)10.1080/10428194.2023.2172981

N/A

0DataRank · unranked

0 citations

Anastasia Tsagianni, Mounzer Agha, Anastasios Raptis, Jing‐Zhou Hou, Rafic Farah +10 more